Latest Hematology & Oncology News
Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Active Surveillance Feasible for Low-Risk Thyroid Cancer
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Coffee Intake Linked to Longer Prostate Cancer-Specific Survival
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Transcranial Doppler, Hydroxyurea Use Low for Sickle Cell Anemia
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Low Placental Growth Factor Predicts Early-Onset Preeclampsia in Patients With SCD 
Majority of Patients in ED With Sickle Cell Crisis Not Triaged Appropriately .jpeg)
Timely Opioid Administration Cuts Hospitalizations for Pediatric Sickle Cell Crises 
Less Than Half of Youths With Sickle Cell Received Dental Services in 2022 Related Articles
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer 
Myeloma Risk Modestly Increased in Adults With Incidentally Detected Vertebral Fracture 
9 of 10 Leading Causes of Death Unchanged From 2023 to 2024 Hematology & Oncology Conference Highlights
Hematology & Oncology Monthly Briefings
Hematology & Oncology Conference News
Stay Connected
